Tevogen Inc. (TVGN) Form 10-Q Quarterly Reports
Tevogen Inc. (TVGN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TVGN
CIK: 1860871
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerJohn Sasselli
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-30 | 2026-09-29 | 8-K | 0001493152-26-045123 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-16 | — | SCHEDULE 13D/A Filing | 0001123292-26-001317 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-16 | — | SCHEDULE 13D/A Filing | 0001123292-26-001316 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001313 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001312 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-14 | 8-K | 0001493152-26-042952 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001307 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001306 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001305 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001304 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001303 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-09 | 8-K | 0001493152-26-042095 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-24 | 8-K | 0001493152-26-040216 | View SEC Doc Filr Page |
| S-8 | 2026-08-24 | — | S-8 | 0001493152-26-039922 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038509 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-03 | 2026-08-03 | DEF 14A | 0001493152-26-035757 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-29 | 8-K | 0001493152-26-035334 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-23 | 2026-07-23 | PRE 14A | 0001493152-26-034442 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-14 | — | SCHEDULE 13D/A Filing | 0001123292-26-001010 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-000996 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-000995 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-000994 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-000993 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-000992 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-000991 | View SEC Doc Filr Page |